Alpha 2.0
Login Register
» Articles » PMID: 19837238

Possible Harms of Oseltamivir--a Call for Urgent Action

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2009 Oct 20
PMID 19837238
Citations 11
Authors
Tom Jefferson
Mark Jones
Peter Doshi
Chris Del Mar
Affiliations
Soon will be listed here.
Citing Articles

Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance.

Okada T, Hashiguchi M, Hori S Int J Clin Pharm. 2022; 44(6):1332-1341.

PMID: 36156764 DOI: 10.1007/s11096-022-01477-6.

Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against Influenza Viruses and .

Popkin D, Zilka S, Dimaano M, Fujioka H, Rackley C, Salata R Pathog Immun. 2017; 2(2):252-269.

PMID: 28936484 PMC: 5605151. DOI: 10.20411/pai.v2i2.200.

Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials.

Hodkinson A, Gamble C, Tudur Smith C Trials. 2016; 17(1):207.

PMID: 27103582 PMC: 4840982. DOI: 10.1186/s13063-016-1327-z.

Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany.

Reuss A, Dehnert M, Buda S, Haas W Influenza Other Respir Viruses. 2013; 7(6):1427-32.

PMID: 23957666 PMC: 4634277. DOI: 10.1111/irv.12152.

Pandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model.

Kaminski M, Ohnemus A, Staeheli P, Rubbenstroth D J Virol. 2012; 87(3):1912-5.

PMID: 23192869 PMC: 3554154. DOI: 10.1128/JVI.02507-12.